Cargando…
Pathological β-Cell Endoplasmic Reticulum Stress in Type 2 Diabetes: Current Evidence
The notion that in diabetes pancreatic β-cells express endoplasmic reticulum (ER) stress markers indicative of increased unfolded protein response (UPR) signaling is no longer in doubt. However, what remains controversial is whether this increase in ER stress response actually contributes importantl...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101261/ https://www.ncbi.nlm.nih.gov/pubmed/33967960 http://dx.doi.org/10.3389/fendo.2021.650158 |
_version_ | 1783688936403501056 |
---|---|
author | Shrestha, Neha De Franco, Elisa Arvan, Peter Cnop, Miriam |
author_facet | Shrestha, Neha De Franco, Elisa Arvan, Peter Cnop, Miriam |
author_sort | Shrestha, Neha |
collection | PubMed |
description | The notion that in diabetes pancreatic β-cells express endoplasmic reticulum (ER) stress markers indicative of increased unfolded protein response (UPR) signaling is no longer in doubt. However, what remains controversial is whether this increase in ER stress response actually contributes importantly to the β-cell failure of type 2 diabetes (akin to ‘terminal UPR’), or whether it represents a coping mechanism that represents the best attempt of β-cells to adapt to changes in metabolic demands as presented by disease progression. Here an intercontinental group of experts review evidence for the role of ER stress in monogenic and type 2 diabetes in an attempt to reconcile these disparate views. Current evidence implies that pancreatic β-cells require a regulated UPR for their development, function and survival, as well as to maintain cellular homeostasis in response to protein misfolding stress. Prolonged ER stress signaling, however, can be detrimental to β-cells, highlighting the importance of “optimal” UPR for ER homeostasis, β-cell function and survival. |
format | Online Article Text |
id | pubmed-8101261 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81012612021-05-07 Pathological β-Cell Endoplasmic Reticulum Stress in Type 2 Diabetes: Current Evidence Shrestha, Neha De Franco, Elisa Arvan, Peter Cnop, Miriam Front Endocrinol (Lausanne) Endocrinology The notion that in diabetes pancreatic β-cells express endoplasmic reticulum (ER) stress markers indicative of increased unfolded protein response (UPR) signaling is no longer in doubt. However, what remains controversial is whether this increase in ER stress response actually contributes importantly to the β-cell failure of type 2 diabetes (akin to ‘terminal UPR’), or whether it represents a coping mechanism that represents the best attempt of β-cells to adapt to changes in metabolic demands as presented by disease progression. Here an intercontinental group of experts review evidence for the role of ER stress in monogenic and type 2 diabetes in an attempt to reconcile these disparate views. Current evidence implies that pancreatic β-cells require a regulated UPR for their development, function and survival, as well as to maintain cellular homeostasis in response to protein misfolding stress. Prolonged ER stress signaling, however, can be detrimental to β-cells, highlighting the importance of “optimal” UPR for ER homeostasis, β-cell function and survival. Frontiers Media S.A. 2021-04-22 /pmc/articles/PMC8101261/ /pubmed/33967960 http://dx.doi.org/10.3389/fendo.2021.650158 Text en Copyright © 2021 Shrestha, De Franco, Arvan and Cnop https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Shrestha, Neha De Franco, Elisa Arvan, Peter Cnop, Miriam Pathological β-Cell Endoplasmic Reticulum Stress in Type 2 Diabetes: Current Evidence |
title | Pathological β-Cell Endoplasmic Reticulum Stress in Type 2 Diabetes: Current Evidence |
title_full | Pathological β-Cell Endoplasmic Reticulum Stress in Type 2 Diabetes: Current Evidence |
title_fullStr | Pathological β-Cell Endoplasmic Reticulum Stress in Type 2 Diabetes: Current Evidence |
title_full_unstemmed | Pathological β-Cell Endoplasmic Reticulum Stress in Type 2 Diabetes: Current Evidence |
title_short | Pathological β-Cell Endoplasmic Reticulum Stress in Type 2 Diabetes: Current Evidence |
title_sort | pathological β-cell endoplasmic reticulum stress in type 2 diabetes: current evidence |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101261/ https://www.ncbi.nlm.nih.gov/pubmed/33967960 http://dx.doi.org/10.3389/fendo.2021.650158 |
work_keys_str_mv | AT shresthaneha pathologicalbcellendoplasmicreticulumstressintype2diabetescurrentevidence AT defrancoelisa pathologicalbcellendoplasmicreticulumstressintype2diabetescurrentevidence AT arvanpeter pathologicalbcellendoplasmicreticulumstressintype2diabetescurrentevidence AT cnopmiriam pathologicalbcellendoplasmicreticulumstressintype2diabetescurrentevidence |